Literature DB >> 11803360

Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report.

M Mohty1, C Faucher, B Gaugler, N Vey, D Sainty, C Arnoulet, M J Mozziconacci, D Isnardon, J A Gastaut, D Maraninchi, D Olive, D Blaise.   

Abstract

We report here the first case of large granular lymphocytes (LGL) expansion following non-myeloablative allo-BMT for chronic myeloid leukemia. We characterized the morphologic, phenotypic and functional features of the LGL subset amplified in vivo 14 months after allo-BMT. Our results indicate that LGL can mediate in vitro a cytolytic activity on tumor cells. In vivo, the timing of the LGL expansion was associated with a sustained complete molecular remission. These observations suggest that LGL are a subset with the properties of effector lymphocytes which may contribute to the graft-versus-tumor effect.

Entities:  

Mesh:

Year:  2001        PMID: 11803360     DOI: 10.1038/sj.bmt.1703308

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia.

Authors:  Dong Hwan Kim; Suzanne Kamel-Reid; Hong Chang; Robert Sutherland; Chul Won Jung; Hyeoung-Joon Kim; Je-Jung Lee; Jeffrey H Lipton
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

2.  [Clinical features and risk factors analyses of patients with T cell large granular lymphocytosis following allo-HSCT].

Authors:  F Zhao; Y Y Shi; G X Zhang; W H Zhai; A M Pang; Q L Ma; R L Zhang; J L Wei; Y Huang; D L Yang; Y He; E L Jiang; S Z Feng; M Z Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

Review 3.  Large granular lymphocytosis after transplantation.

Authors:  Zhi-Yuan Qiu; Guang-Yu Tian; Zhao Zhang; Ye-Qing Zhang; Wei Xu; Jian-Yong Li
Journal:  Oncotarget       Date:  2017-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.